02192.HK
Medlive Technology Co., Ltd.
HKSE · Healthcare · Medical - Distribution · CN
HKD 7.05
+0.64%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.3B | 642.2M | 558.5M | 412.0M | 314.1M |
| Cost of Revenue | 511.2M | 256.7M | 231.2M | 160.7M | 101.3M |
| Gross Profit | 756.8M | 385.4M | 327.2M | 251.3M | 212.7M |
| Operating Expenses | |||||
| R&D Expense | 141.9M | 76.5M | 64.6M | 60.0M | 46.2M |
| SG&A Expense | 400.1M | 217.0M | 209.0M | 177.3M | 151.3M |
| General & Admin Expense | 282.1M | 182.6M | 175.6M | 144.5M | 122.4M |
| Selling & Marketing Expense | 50.9M | 34.1M | 33.4M | 32.8M | 28.9M |
| Other Expenses | — | — | — | 54.3M | — |
| Total Operating Expenses | 542.0M | 293.6M | 273.6M | 231.5M | 197.6M |
| Cost and Expenses | 1.1B | 550.3M | 504.8M | 392.2M | 298.9M |
| Operating Income (EBIT) | 214.8M | 91.9M | 53.6M | 19.8M | 15.2M |
| Non-Operating | |||||
| Interest Income | 365.6M | 177.6M | 204.7M | 183.9M | 66.2M |
| Interest Expense | 474.7K | 552.0K | 786.0K | 361.0K | 531.0K |
| Net Interest Income | 365.1M | 177.0M | 203.9M | 183.5M | 65.7M |
| Other Non-Op Income/Expense | 503.5M | 268.4M | 286.8M | 233.3M | 119.9M |
| Non-Operating Income (excl Interest) | (109.1M) | (75.5M) | (63.8M) | (175.7M) | (66.2M) |
| EBT (Pre-Tax Income) | 718.3M | 360.3M | 340.5M | 253.1M | 135.0M |
| Income Tax Expense | 27.3M | 12.4M | 10.2M | 1.4M | 8.6M |
| Bottom Line | |||||
| Net Income | 662.1M | 334.3M | 315.1M | 242.3M | 117.3M |
| Earnings from Cont. Ops | 691.0M | 347.9M | 330.3M | 251.8M | 126.4M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 662.1M | 334.3M | 315.1M | 242.3M | 117.3M |
| Per Share | |||||
| Basic EPS | HK$0.90 | HK$0.45 | HK$0.43 | HK$0.33 | HK$0.16 |
| Diluted EPS | HK$0.90 | HK$0.45 | HK$0.43 | HK$0.33 | HK$0.16 |
| Revenue Per Share | HK$1.72 | HK$0.87 | HK$0.76 | HK$0.56 | HK$0.44 |
| Shares | |||||
| Basic Shares Outstanding | 738.7M | 736.7M | 736.3M | 734.5M | 714.4M |
| Diluted Shares Outstanding | 739.3M | 736.7M | 736.3M | 734.6M | 736.5M |
| Profitability Metrics | |||||
| EBITDA | 333.0M | 175.0M | 121.4M | 262.9M | 144.6M |
| D&A | 9.1M | 7.6M | 3.9M | 9.4M | 9.0M |
| EBIT | 323.9M | 167.4M | 117.4M | 253.5M | 135.6M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026